Showing 34,803 results

New & experimental HIV treatments

IAS 2021: Injectable treatment for multidrug-resistant HIV Video

July 2021
Injectable & long-acting HIV treatment

IAS 2021: Injectable lenacapavir for people starting HIV treatment Video

July 2021

IAS 2021: Trattamento precoce e conte CD4 più elevate associati a una riduzione dei reservoir HIV, Giovedì 22 luglio 2021

July 2021

IAS 2021: Раннее начало терапии при более высоких показателях CD4 ассоциируется с меньшим объемом ВИЧ-резервуаров, Четверг, 22 июля 2021 г.

July 2021
Transgender people

Studies confirm that hormone levels in trans women are not greatly affected by PrEP, or vice versa

News
22 July 2021
Access to healthcare

HIV: Breakthrough in cryptococcal meningitis gives Gilead opportunity to fulfil promise to scale up access to key drug

Editor's pick
MSF
22 July 2021
Global health targets

UNAIDS sets new targets after missing most recent goals

Editor's pick
Devex
22 July 2021
HIV treatment for children & young people

New report reveals stark inequalities in access to HIV prevention and treatment services for children—partners call for urgent action

Editor's pick
UNAIDS
22 July 2021
Harm reduction

US Congress Plans Historic Federal Funding for Syringe Programs

Editor's pick
Filter
22 July 2021

IAS 2021: Un traitement précoce et un taux de cellules T CD4 élevé sont associés à un réservoir viral plus faible, Jeudi 22 juillet 2021

July 2021

IAS 2021: Tratamento precoce e contagens de CD4 mais altas ligadas a um reservatório menor de VIH, Quinta-feira, 22 de julho de 2021

July 2021

IAS 2021: Un inicio más temprano del tratamiento y un nivel más elevado de CD4, vinculados a un menor reservorio viral, Jueves, 22 de julio de 2021

July 2021

IAS 2021: Earlier treatment and higher CD4 counts linked to smaller HIV reservoir, Thursday 22 July 2021

July 2021
Improving HIV care

What Will Bring People Living With HIV Back Into Care?

Editor's pick
POZ
22 July 2021
Injectable & long-acting PrEP

Modelling suggests injectable cabotegravir is far more effective than daily oral PrEP for women

News
22 July 2021
Transgender people

How can HIV research better align with the realities of transgender and gender-diverse people?

News
22 July 2021

IAS 2021: Rischio di COVID-19 grave più elevato con basse conte CD4 e mancata soppressione HIV, Mercoledì 21 luglio 2021

July 2021
Drug-resistant TB

Shorter, less toxic treatment for highly drug-resistant TB cures nine out of ten

News
21 July 2021
The search for a cure

Earlier treatment and higher CD4 counts linked to smaller HIV reservoir

News
21 July 2021

IAS 2021: Un taux faible de cellules T CD4 et une charge virale détectable augmentent les risques de COVID-19 grave, Mercredi 21 juillet 2021

July 2021

IAS 2021: Tener niveles bajos de CD4 y una carga viral del VIH detectable aumentan el riesgo de sufrir un caso grave de COVID-19, Miércoles, 21 de julio de 2021

July 2021

IAS 2021: Contagem de CD4 mais baixa e VIH não suprimido aumentam o risco de COVID-19 grave, Quarta-feira, 21 de julho de 2021

July 2021
Injectable & long-acting PrEP

IAS: Merck's long-acting HIV med hits protective levels in phase 2

Editor's pick
FierceBiotech
21 July 2021

IAS 2021: Lower CD4 count and unsuppressed HIV raise risk for severe COVID-19, Wednesday 21 July 2021

July 2021